Bupropion Extended-Release Tablets and Moxetumomab pasudotox
Determining the interaction of Bupropion Extended-Release Tablets and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Extended-Release Tablets-Moxetumomab Pasudotox-tdfk
- Bupropion Extended-Release Tablets-Moxetumomab pasudotox-tdfk Intravenous
- Bupropion Extended-Release Tablets-Moxifloxacin
- Bupropion Extended-Release Tablets-Moxifloxacin (Systemic)
- Bupropion Extended-Release Tablets-Moxifloxacin Hydrochloride
- Bupropion Extended-Release Tablets-Moxifloxacin Injection
- Moxetumomab pasudotox-Bupropion Hydrochloride
- Moxetumomab pasudotox-Bupropion SR Tablets
- Moxetumomab pasudotox-Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Moxetumomab pasudotox-Bupropion Tablets
- Moxetumomab pasudotox-Bupropion Tablets and Sustained-Release Tablets
- Moxetumomab pasudotox-Burapren Injection